Track Medico Remedies Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -5.49 %
Low
44.7
High
52.8
1 Month returns: 16.33 %
Low
37.0
High
52.8
1 Year returns: 18.72 %
Low
30.2
High
57.0
3 Year CAGR: -16.63 %
Low
30.2
High
92.9
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Medico Remedies Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Medico Remedies Ltd. Shareholding Pattern
Quarterly breakdown of Medico Remedies Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Medico Remedies Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Medico Remedies Ltd.?
The current share price of Medico Remedies Ltd. is ₹ 46.30 as of 7 Aug 2026.
What is the market capitalisation of Medico Remedies Ltd.?
The market capitalisation of Medico Remedies Ltd. stands at ₹ 384.22 Cr.
What is the PE ratio of Medico Remedies Ltd.?
The Price-to-Earnings (PE) ratio of Medico Remedies Ltd. is 29.30 as of the latest trailing twelve months data.
What is the ROE and ROCE of Medico Remedies Ltd.?
Medico Remedies Ltd. has a Return on Equity (ROE) of 19.02% and a Return on Capital Employed (ROCE) of 16.21% as per the latest financial reports.
What is the 52-week high and low of Medico Remedies Ltd.?
The 52-week high of Medico Remedies Ltd. is - and the 52-week low is -.
What is the dividend yield of Medico Remedies Ltd.?
The dividend yield of Medico Remedies Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Medico Remedies Ltd.?
Foreign Institutional Investors (FII) hold 0.08%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 33.82% of Medico Remedies Ltd. shares.
What sector does Medico Remedies Ltd. belong to?
Medico Remedies Ltd. operates in the Healthcare sector.
What is the beta of Medico Remedies Ltd.?
The beta of Medico Remedies Ltd. is 0.95, indicating its price volatility relative to the broader market. Over the past 1 year, Medico Remedies Ltd. has delivered an absolute return of 12.11%.
What is the RSI of Medico Remedies Ltd.?
The 14-day Relative Strength Index (RSI) of Medico Remedies Ltd. is 61.50, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Medico Remedies Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Expensive and at same valuation levels as industry median P/E
PE TTM of 29.3 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at -4.22%
What is P/E Ratio?
Median: 30.59
Value 29.3
0.33286.35
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 36.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
36.1 / 100
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (STASM - I (11)).
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Sep 2018
Mar 2019
Sep 2019
Mar 2020
Sep 2020
Mar 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
66.83
63.79
62.59
61.38
61.38
61.38
61.38
Indian Promoter
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
73.34
66.83
63.79
62.59
61.38
61.38
61.38
61.38
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
-
-
-
-
-
-
-
-
-
-
0.00
0.00
0.53
1.20
1.12
1.29
1.03
1.20
1.19
1.17
0.13
0.08
0.31
0.49
0.03
0.08
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.53
1.19
1.11
1.29
0.29
0.22
0.22
0.39
0.11
0.07
0.30
0.49
0.03
0.08
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.74
0.97
0.97
0.78
0.01
0.01
0.01
0.00
0.00
0.00
Non-Institution
26.66
26.66
26.66
26.66
26.66
26.66
26.66
26.66
26.66
26.66
26.66
26.66
26.14
25.47
25.55
25.37
25.63
25.47
25.47
32.00
36.08
37.33
38.30
38.13
38.59
38.54
Bodies Corporate
20.42
20.85
-
-
19.93
18.16
19.61
19.16
19.25
19.19
16.62
13.49
11.22
9.78
9.45
7.66
6.29
2.14
2.04
4.59
4.62
4.76
5.45
5.42
4.81
4.72
Others (incl. Retail)
No. of shareholders
6.24
122
5.81
105
26.66
113
26.66
111
6.73
98
8.50
89
7.05
70
7.50
101
7.41
100
7.47
477
10.04
750
13.17
1,740
14.92
3,256
15.69
5,013
16.10
5,221
17.71
6,007
19.34
10,641
23.33
12,852
23.43
12,833
27.41
14,014
31.46
15,346
32.57
16,396
32.85
18,418
32.71
16,482
33.78
16,107
33.82
15,786
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
Harshit H Mehta HUF
Promoter
December-2024
Market Sale (Disposal)
26th Dec 2024
0.32 %
₹ 48.52
2.50 lac
₹ 1.21 cr
Harshit H Mehta HUF
Promoter
December-2024
Market Sale (Disposal)
26th Dec 2024
0.80 %
₹ 49.01
4.00 lac
₹ 1.96 cr
Shweta Harshit Mehta
Promoter Group
December-2024
Market Sale (Disposal)
26th Dec 2024
7.66 %
₹ 48.50
2.00 lac
₹ 97.00 lac
Rishit Haresh Mehta
Promoter Group
December-2024
Market Sale (Disposal)
5th Dec 2024
13.13 %
₹ 45.02
4.00 lac
₹ 1.80 cr
Rishit Haresh Mehta
Promoter Group
December-2024
Market Sale (Disposal)
5th Dec 2024
14.82 %
₹ 45.01
14.00 lac
₹ 6.30 cr
Harshit H Mehta HUF
Promoter
November-2024
Market Sale (Disposal)
20th Nov 2024
0.87 %
₹ 50.65
52.94 k
₹ 26.81 lac
Rita Haresh Mehta
Promoter
November-2024
Market Sale (Disposal)
20th Nov 2024
10.40 %
₹ 50.69
18.00 lac
₹ 9.13 cr
Shweta Harshit Mehta
Promoter Group
November-2024
Market Sale (Disposal)
20th Nov 2024
8.75 %
₹ 50.65
9.00 lac
₹ 4.56 cr
Haresh Kapurlal Mehta
Promoter & Director
January-2024
Inter-se Transfer (Disposal)
10th Jan 2024
28.45 %
₹ 0.00
63.83 lac
₹ 0.00
Harshit Haresh Mehta
Promoter & Director
January-2024
Inter-se Transfer (Acquisition)
10th Jan 2024
9.11 %
₹ 0.00
19.60 lac
₹ 0.00
Corporate Actions
History of Medico Remedies Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Stock Split1 : 5
Ex-date: 16th Mar 2023Announced on: 2nd Feb 2023
Nominal value change from INR 10 to INR 2.
Bonus3 new shares for 1 existing shares
Ex-date: 16th Nov 2021Announced on: 7th Oct 2021
Company Profile
Overview of Medico Remedies Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretrovir...
Key personnel
Mr. Kunal Vora
Additional Non-Executive Independent Director
Ms. Vidhi Ankit Shah
Compliance Officer, Company Secretary
Mr. Gopal Jha
Administration Manager
Mrs. Priyal Mehta
Marketing Manager
Mr. Dushant Pandey
Quality Control Manager
Mr. Haresh MehtaD
Chairman of the Board, Legal Head and Chief Financial Officer
Mr. Harshit Haresh MehtaD
Managing Director, Marketing & Export Head and Executive Director
Mr. Rishit Hareshbhai (Rishi) MehtaD
Production - Technical & Quality Control Head and Whole-time Director